Anti-equine Fc epsilon receptor alpha chain antibodies and...

Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C435S007500, C435S007700, C435S007800, C435S007920, C436S501000, C436S507000, C436S513000, C436S526000, C436S527000, C436S530000, C436S533000, C436S534000, C436S536000, C436S539000, C436S542000, C436S546000, C530S395000

Reexamination Certificate

active

06887672

ABSTRACT:
The present invention relates to equine Fc epsilon receptor alpha chain nucleic acid molecules, proteins encoded by such nucleic acid molecules, antibodies raised against such proteins, and inhibitors of such proteins. The present invention also includes methods to detect IgE using such proteins and antibodies. Also included in the present invention are therapeutic compositions comprising such proteins, nucleic acid molecules, antibodies and/or inhibitory compounds as well as the use of such therapeutic compositions to mediate Fc epsilon receptor-mediated biological responses.

REFERENCES:
patent: 6582701 (2003-06-01), Weber et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Anti-equine Fc epsilon receptor alpha chain antibodies and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Anti-equine Fc epsilon receptor alpha chain antibodies and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-equine Fc epsilon receptor alpha chain antibodies and... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3402668

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.